An Israeli company has developed the Discovery NM/CT 670 CZT system to perform faster, more accurate, safer and less intrusive SPECT/CT scans of the body; Israeli biotech Oramed has reported success in the Phase IIb study of its insulin capsule, and much more.

| Share: